Health Canada has announced that drugs for Attention Deficit Hyperactivity Disorder (ADHD) will come with stronger and clearer warnings on the risks of suicidal thoughts and behaviors. According to the health agency, the new warnings are based on reports of suicidal thoughts, suicide attempts and in a very small number of cases, completed suicide. The warning is already in place for one ADHD drug, Strattera (atomoxetine), which had the risk information added ...
http://ift.tt/19MDR16
http://ift.tt/1BWgEAm
No comments:
Post a Comment